Mid-Morning Market Update: Markets Open Higher; Lowe's Posts Mixed Q4 Results

Following the market opening Wednesday, the Dow traded up 0.81% to 27301.35 while the NASDAQ rose 1.04% to 9058.97. The S&P also rose, gaining 0.84% to 3154.38.

Leading and Lagging Sectors

Information technology shares climbed 1.3% on Wednesday. Meanwhile, top gainers in the sector included Opera Limited OPRA, up 11%, and Plantronics, Inc. PLT, up 7%.

In trading on Wednesday, real estate shares fell 0.1%.

Top Headline

Lowe's Companies, Inc. LOW reported stronger-than-expected earnings for its fourth quarter, while sales missed views. The company also issued weak earnings outlook for FY20.

Lowe's reported quarterly earnings of $0.94 per share, which beat the analyst consensus estimate of $0.91. The company reported quarterly sales of $16.03 billion, which missed the analyst consensus estimate of $16.17 billion.

Lowe's said it expects FY20 adjusted earnings of $6.45 to $6.65 per share, versus analysts’ estimates of $6.67 per share.

 

Equities Trading UP

SELLAS Life Sciences Group, Inc. SLS shares shot up 44% to $2.97 after the company reported follow-up Phase 1/2 clinical data for Galinpepimut-S in acute myeloid leukemia.

Shares of Tarena International, Inc. TEDU got a boost, shooting 40% to $3.95 after gaining 19.5% on Tuesday.

Novavax, Inc. NVAX shares were also up, gaining 31% to $10.36 after the company highlighted progress in efforts to develop novel vaccine to protect against coronavirus.


Equities Trading DOWN

Spherix Incorporated SPEX shares tumbled 30% to $1.72 after climbing around 137% on Tuesday.

Shares of SmileDirectClub, Inc. SDC were down 27% to $8.24 after the company reported worse-than-expected Q4 results. Jefferies downgraded SmileDirectClub from Buy to Hold and lowered the price target from $22 to $10.

Menlo Therapeutics Inc. MNLO was down, falling 23% to $3.37. Menlo Therapeutics said its Phase 2 study of serlopitant for the treatment of chronic pruritus of unknown origin did not meet the primary endpoint of showing a statistically significant reduction in pruritus in patients treated with serlopitant compared to placebo based upon a 4-point improvement responder analysis.

Commodities


In commodity news, oil traded down 1.2% to $49.31, while gold traded down 0.3% to $1,645.10.

Silver traded down 1.2% Wednesday to $17.975, while copper fell 0.9% to $2.5545.

Euro zone

European shares were mostly lower today. The eurozone’s STOXX 600 dropped 1.1% the Spanish Ibex Index declined 0.1%, while Italy’s FTSE MIB Index gained 0.4% Meanwhile, the German DAX dropped 0.9%, and the French CAC 40 fell 0.7% while UK shares fell 0.7%.

Economics

New home sales rose 7.9% to an annual rate of 764,000 in January.

The Energy Information Administration’s weekly report on petroleum inventories in the U.S. will be released at 10:30 a.m. ET.

The business expectations and uncertainty indexes for February will be released at 11:00 a.m. ET.

Federal Reserve Bank of Minneapolis President Neel Kashkari will speak at 1:00 p.m. ET.

The Treasury is set to auction 5-year notes at 1:00 p.m. ET.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsEurozoneCommoditiesGlobalIntraday UpdateMarketsConsumer DiscretionaryHome Improvement RetailMid-Morning Market Update
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!